Curtiss-Wright CapEx decreased by 68.6% to $11.83M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 25.0%, from $15.77M to $11.83M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 21.5% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.23M | $10.09M | $13.25M | $10.90M | $8.60M | $9.30M | $9.43M | $10.66M | $12.00M | $9.37M | $12.63M | $12.06M | $11.06M | $14.58M | $23.27M | $15.77M | $19.38M | $16.90M | $37.64M | $11.83M |
| QoQ Change | — | +9.2% | +31.4% | -17.8% | -21.1% | +8.2% | +1.4% | +13.1% | +12.6% | -21.9% | +34.7% | -4.5% | -8.2% | +31.8% | +59.6% | -32.2% | +22.9% | -12.8% | +122.7% | -68.6% |
| YoY Change | — | — | — | — | -6.9% | -7.8% | -28.8% | -2.2% | +39.6% | +0.8% | +34.0% | +13.1% | -7.8% | +55.6% | +84.3% | +30.8% | +75.2% | +15.9% | +61.7% | -25.0% |